IMPORTANCE Initial treatment of nasal fractures can result in long-standing cosmetic or functional defects, but the risk factors for subsequent septorhinoplasty have not been explored.
N asal fractures represent one of the most common traumatic injuries to the face, with close to 40% of all facial fractures involving the nose. 1 Treatment decisions must address the acute presentation of the injury while optimizing long-term functional and cosmetic outcomes. [2] [3] [4] Many treatment algorithms have, therefore, been devised to guide the classification and management of nasal fractures, but few studies have assessed the association between early treatment approaches and the likelihood of subsequent revision surgery. 5 A recent systematic review found no evidence that closed and open reduction procedures result in different rates of nasal deformity, 3 whereas other studies have suggested that open reduction or concomitant septorhinoplasty, compared with closed reduction treatment, can reduce the risk of subsequent surgery. 1, 5, 6 Many of these studies, however, are limited in power because of their small sample size and rely on single-institution samples that may not be generalizable to all populations or geographies. Therefore, further analysis is needed to understand the association between the initial nasal fracture treatment and the likelihood of subsequent septorhinoplasty to better inform patients and physicians in the setting of acute injury. The objective of this study was to conduct a population-based analysis of a large insurance claims database to characterize initial treatment pathways for isolated nasal fracture and to determine the factors associated with septorhinoplasty after initial treatment.
Methods

Data and Study Cohort
A retrospective analysis of insurance claims data was conducted for the period January 1, 2007, through December 31, 2015, using the Commercial and Medicare Supplemental categories of the Truven Health MarketScan database. The database represents more than 200 million individuals across the United States who receive health insurance from self-insured employers and other private health plans and includes claims for inpatient and outpatient services as well as for outpatient pharmacy. Patients with Medicaid and original Medicare were not included. Procedures were identified using Current Procedural Terminology codes, and diagnoses used International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9 CM) codes (eTable in the Supplement). The Research and Compliance Office of Stanford University deemed this study exempt from human studies review.
All patients diagnosed with an isolated nasal fracture (ICD-9 CM code 802.0 or 802.1) were identified, and the date of the earliest encounter with nasal fracture diagnosis was recorded as the date of incidence. Patients were excluded if diagnosed with other facial fractures (eg, to the mandible, maxillary bones, or orbit) on the same date to limit the analysis to isolated nasal fractures. To ensure that observations reflected incident cases and that sufficient follow-up data were collected, patients were required to have 12 months of continuous enrollment prior to their nasal fracture diagnosis and 24 months of continuous enrollment after diagnosis. Follow-up time was standardized for all patients at 24 months.
Explanatory Variables
To assess treatment pathways immediately after nasal fracture, patients were classified into 1 of 4 groups according to the type and timing of treatment: (1) closed reduction treatment within 3 weeks of fracture; (2) open treatment within 3 weeks of fracture; (3) open treatment between 3 weeks and 6 months after fracture; or (4) observation, where neither closed nor open treatment was performed within 6 months after fracture. Open treatment included both open reduction and septorhinoplasty procedures to account for potential variation in coding practices and instances in which open reduction and septorhinoplasty were performed concurrently. 7 Patients treated with closed reduction later than 3 weeks after fracture were excluded, as this method is unlikely to be effective and is infrequently performed after this point. 5, 8 The closed reduction and open treatment cohorts were further divided into subgroups on the basis of treatment timing: (1) closed reduction treatment between 0 and 10 days and between 11 and 21 days after fracture and (2) open treatment between 0 and 10 days, between 11 and 21 days, and between 22 days and 6 months after fracture. Other patient and treatment characteristics included age; sex; insurance plan type; geographic region; and whether patients lived in an urban area, defined as any geography within a metropolitan statistical area. 6, 9, 10 Treatment characteristics were also collected, such as time from nasal fracture to initial treatment (for patients with closed reduction treatment or open treatment) and time from fracture to first septorhinoplasty after initial treatment. Specific comorbidities captured included history of tobacco use, autoimmune disease or immunodeficiency, anxiety, deviated septum, turbinate hypertrophy, nasal obstruction, acquired deformity of the nose, congenital deformity of the nose, late effect of prior nasal injury, and malunion of prior nasal injury (eTable in the Supplement). 9 These comorbidities were assessed in the year preceding 2 weeks prior to the fracture date, to ensure that they did not arise alongside the incident nasal fracture episode. Patients' general comorbidity burden was also measured using the
Key Points
Question What are the risk factors for septorhinoplasty after the initial treatment of isolated nasal fracture?
Findings This population-based analysis of 78 474 patients found that open treatment was associated with increased risk of subsequent septorhinoplasty in patients without a preexisting nasal obstruction or defect. In patients with a preexisting obstruction or defect, an observation-only approach was associated with greatest risk.
Meaning Preexisting nasal obstruction or defect and other aspects of a patient's history should be considered when managing nasal fracture to assess the likelihood of surgical revision.
van Walraven formulation of the Elixhauser Comorbidity Index, which encapsulates 30 common comorbidities as a single numeric score that represents association with mortality.
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Outcome Variables
The primary outcome was the occurrence of septorhinoplasty, as defined by any record of a corresponding billing code (eTable in the Supplement) between 6 and 24 months after the initial diagnosis of nasal fracture, when edema has resolved and the nasal bones and septum have stabilized sufficiently for surgery.
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Statistical Methods
Descriptive statistics were used to summarize the distribution of variables across the study cohort. Differences in the van Walraven comorbidity index across the 4 treatment cohorts were tested for statistical significance using the nonparametric Kruskal-Wallis rank sum analysis of variance, and distributions of categorical variables were tested using a χ 2 test.
Differences in subsequent septorhinoplasty rates across treatment cohorts and among timing-based subgroups within a treatment cohort were assessed for statistical significance using a 2-tailed population proportion test. Statistical significance was determined at a threshold of P = .05. The effect of a covariate on the risk of septorhinoplasty between 6 and 24 months after nasal fracture was assessed using multivariable logistic regression and was described as an adjusted odds ratio (aOR) that controls for the effect of other covariates. Additional multiple logistic regression models included interaction terms to assess the interactions of interest. Unadjusted ORs calculated from univariable logistic regression were also recorded for each covariate. Estimates were reported with 95% CIs.
Data extraction and manipulation were performed using SAS, version 9.4 (SAS Institute Inc), and further statistical analysis was performed using R, version 3.4.2 (R Foundation for Statistical Computing). Table 1) . Rates of septorhinoplasty between 6 and 24 months after nasal fracture were 1.7% (896 of 52 288) for observation, 1.6% (331 of 20 357) for closed reduction treatment, 3.6% (123 of 3417) for open treatment within 3 weeks of fracture, and 2.9% (71 of 2412) for open treatment between 3 weeks and 6 months after fracture ( Table 2 )-differences that were statistically significant (P < .001). Among patients treated with closed reduction, 1.6% (298 of 18 912) treated between 0 and 10 days after fracture had subsequent septorhinoplasty, compared with 2.3% (33 of 1445) of those treated between 11 and 21 days after fracture, a difference that was not statistically significant (P = .05).
Results
Patient Characteristics
Initial Treatment and Rates of Subsequent Septorhinoplasty
Among patients with open treatment, 3.4% (95 of 2766) treated criteria. There are patients who both did not meet enrollment criteria and had concomitant facial fracture. Adding the number of patients who met each exclusion criterion will result in a sum that is greater than the total number of patients excluded. 
Factors in Subsequent Septorhinoplasty
Multivariable logistic regression identified several factors that were independently associated with risk of septorhinoplasty between 6 and 24 months after nasal fracture ( 
Discussion
Previous studies that have assessed outcomes after management of nasal fracture may be limited by small sample size and poor generalizability. The present study represents, to our knowledge, the first population-based analysis of treatment pathways after nasal fracture and risk factors associated with septorhinoplasty after initial fracture treatment.
Most patients in the final study cohort were managed with observation alone after nasal fracture; of the patients who were treated, closed reduction treatment was more common than open treatment. The observation-only and closed reduction treatment groups had similar rates of subsequent septorhinoplasty (1.7% and 1.6%, respectively), whereas open treatment was associated with a higher rate of subsequent surgery (3.6% when treated within 3 weeks of fracture, and 2.9% when treated between 3 weeks and 6 months after fracture). Within the open treatment and closed reduction treatment groups, no statistically significant difference was observed in subsequent septorhinoplasty rates among the subgroups split by timing of treatment after fracture. The association of initial treatment with the risk of subsequent septorhinoplasty depended on whether a preexisting diagnosis of nasal obstruction or defect was present. In patients without a preexisting diagnosis of nasal obstruction or defect, open treatment was found to increase the likelihood of subsequent septorhinoplasty, compared with observation or closed reduction treatment. Fractures involving other facial bones were excluded, but this analysis could not directly account for differences in the mean severity of nasal fractures treated by each approach. Open treatment involving limited septoplasty or osteotomy may be more common among fractures with increased severity and therefore be more strongly associated with subsequent septorhinoplasty. 13 Similarly, reduced complexity cases with minimal changes in nasal bone alignment or airway patency may be managed with either observation or closed reduction treatment, resulting in lower subsequent septorhinoplasty rates. 12 Therefore, it is possible that the open treatment groups had a higher mean treatment severity compared with the closed reduction treatment and observation groups and thus had greater risk of subsequent septorhinoplasty among patients without a preexisting nasal obstruction or defect. However, among patients who had a preexisting diagnosis of nasal obstruction or defect, those treated more conservatively with observation had a greater risk of subsequent surgery than those in the open treatment groups. In addition, preexisting diagnosis of nasal obstruction or defect was found to increase the risk of subsequent septorhinoplasty for both the observation and closed reduction treatment groups. Previous studies have established that a preexisting nasal obstruction or defect may decrease the likelihood that a closed reduction treatment is successful and that open treatment may therefore be more appropriate in this setting.
5,10,13-16 Our findings support the hypothesis that conservative treatment in the presence of a preexisting obstruction or defect may increase the likelihood of revision surgery in the future, compared with an open treatment approach; this conclusion warrants further prospective study. Furthermore, this association may be greater than the degree of confounding within our analysis from different mean severity among treatment groups, which may explain why initial treatment was not associated with subsequent septorhinoplasty when assessed across the entire study cohort without accounting for interaction with a preexisting nasal obstruction or defect.
Other factors independently associated with increased risk of subsequent septorhinoplasty after initial nasal fracture treatment were age younger than 65 years, female sex, urban area, western US region, and a history of anxiety, many of which agree with previously reported findings. 9 Specifically, Honigman et al 17 report that psychological comorbidities, including anxiety, are associated with poor psychological outcomes and patient dissatisfaction after cosmetic surgery, which may predispose patients to seek future surgical revision independent of technical outcome. With respect to the association between urban environment and septorhinoplasty after initial fracture treatment, previous studies have described an asymmetric distribution of surgeons across the United States: A disproportionately high concentration of surgeons practice in urban areas, where demand-especially for more highly reimbursed cosmetic procedures-is higher. 18, 19 Patients living in rural areas may, therefore, face greater travel distance and time to undergo septorhinoplasty, decreasing their access to this elective specialist care.
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Limitations
The limitations of this study are primarily associated with the insurance claims database used. First, the database includes only procedures that have been reimbursed by insurance; thus, procedures paid out of pocket or deemed medically unnecessary are not captured. Our analysis is, therefore, more complete for septorhinoplasty procedures that have a functional component because purely cosmetic procedures are unlikely to be reimbursed, which may underestimate the true rate of septorhinoplasty after nasal fracture. Likewise, this analysis is only valid for patients with commercial or supplemental Medicare insurance, as Medicaid and original Medicare patients are not included in this database. Second, more than 75% of patients diagnosed with nasal fracture were excluded from our analysis, nearly all of whom did not fulfill enrollment criteria. Consequently, this analysis is only valid for the population of patients with characteristics similar to those of the final study cohort. Finally, clinical or patient-reported outcomes, operative techniques, or other variables (eg, provider type, race/ ethnicity, socioeconomic status) that are not explicitly or unambiguously coded for billing purposes could not be assessed, necessitating further prospective study in these areas. 22 
Conclusions
Clinical practice guidelines for rhinoplasty emphasize the importance of educating patients undergoing treatment for nasal injury about the risk of future follow-up surgery, which can be associated with morbidity and increased costs. 23 To our knowledge, this analysis represents the first populationbased study of initial treatment pathways after isolated nasal fracture, and it provides valuable information regarding the risk factors for subsequent corrective septorhinoplasty. Future prospective studies are needed to validate our results, but we believe that a preexisting diagnosis of nasal obstruction or defect as well as other aspects of a patient's history should be considered when managing nasal fractures to assess the likelihood of surgical revision. b Preexisting nasal obstruction or defect defined as the diagnosis of deviated septum, nasal obstruction, acquired and congenital deformities of the nose, late effect of fracture of skull and face, and malunion of previous fracture.
